|
Vincent, call your office. |
Yes, there's good news out there: breakthroughs in the world of medicine:
People in need of surgery to repair or reconstruct damaged cartilage could soon find help in an unlikely place -- their ears.
Stem cells from human ears have successfully been grown into chunks of cartilage that could replace the synthetic materials currently used in surgery.
Stem cell researchers are trying to grow
spare parts for the human heart that may be ready for tests on people within five years. Scientists have already made basic heart muscle from stem cells, but the team wants to refine it so it can replace any part damaged in heart attacks, and to recreate the natural pacemaker, where the heartbeat originates.
In a bit of high-tech recycling, researchers have developed an innovative way to identify already-approved drugs that may work against diseases they weren't designed to combat. The scientists have also demonstrated how a couple of such
repurposed drugs may have benefits in treating two conditions, inflammatory bowel disease and lung cancer. The researchers found that topiramate, a drug used in epilepsy, might work on inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Another hit suggested that cimetidine, an ulcer drug, might be effective in lung cancer. They then tested the two generic drugs in small studies using animal models of the diseases. In the bowel-disease study, the drug reduced symptoms, and in the lung-cancer paper, the drug was found to slow tumor growth.
Researchers have found a protein normally involved in blood pressure regulation in a surprising place: tucked within the little "power plants" of cells, the mitochondria. The quantity of this protein appears to decrease with age, but treating older mice with the blood pressure medication losartan can increase protein numbers to youthful levels, decreasing both blood pressure and cellular energy usage. The researchers say these findings may lead to new treatments for mitochondrial–specific,
age-related diseases, such as diabetes, hearing loss, frailty and Parkinson's disease.
A biomedical engineer has developed a
lab-on-a-chip that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world. It requires only a tiny finger prick of blood, effective even for a newborn, and gives results in less than 15 minutes. This technology significantly reduces the time between testing and treating. New low-cost diagnostics like the mChip could revolutionize medical care around the world.